World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
15386
World Ranking
3402
National Ranking
1578

Mark C. Liu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark C. Liu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 138 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark C. Liu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark C. Liu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark C. Liu is affiliated with Johns Hopkins University in the United States and conducts research primarily within the field of Medicine. Their work focuses extensively on subfields such as Physiology, Pulmonary and Respiratory Medicine, Surgery, Immunology, and Statistics and Probability.

The scientist's research topics include:

  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Eosinophilic Esophagitis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Statistical Methods in Clinical Trials
  • Eosinophilic Disorders and Syndromes
  • Immune Cell Function and Interaction

Mark C. Liu has contributed to several publications, with a particular focus on severe asthma and eosinophilic conditions. Key recent papers include:

  • "From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases" (2021), published in Allergy
  • "The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions" (2021), Journal of Allergy and Clinical Immunology
  • "Sex differences in M2 polarization, chemokine and IL-4 receptors in monocytes and macrophages from asthmatics" (2020), Cellular Immunology
  • "PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment" (2021), Journal of Allergy and Clinical Immunology
  • "Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics" (2021), Respiratory Research

The frequent publication venues for their work include:

  • Journal of Allergy and Clinical Immunology
  • Respiratory Research
  • The Journal of Allergy and Clinical Immunology In Practice
  • Allergy
  • Cellular Immunology

Mark C. Liu regularly collaborates with several researchers, including:

  • Michael E. Wechsler
  • Jerry A. Krishnan
  • Steven W. Yancey
  • Steve N. Georas
  • Rosalind J. Wright

Best Publications

  • Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

    Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle

  • Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions

    Sally E. Wenzel;John V. Fahy;Charles Irvin;Stephen P. Peters

  • Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.

    Mark C. Liu;Walter C. Hubbard;David Proud;Becky A. Stealey

  • Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis.

    David R. Moller;Jeffrey D. Forman;Mark C. Liu;Paul W. Noble

  • Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial

    Mark C. Liu;Louise M. Dubé;James Lancaster

  • Evidence for Elevated Levels of Histamine, Prostaglandin D2, and Other Bronchoconstricting Prostaglandins in the Airways of Subjects with Mild Asthma

    Mark C. Liu;Eugene R. Bleecker;Lawrence M. Lichtenstein;Anne Kagey-Sobotka

  • Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

    Edward S. Chen;Zhimin Song;Matthew H. Willett;Shannon Heine

  • Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.

    C Stellato;P Collins;P D Ponath;D Soler

  • Inflammatory cells in asthma: Mechanisms and implications for therapy

    Qutayba Hamid;Meri K. Tulic;Mark C. Liu;Redwan Moqbel

  • Identification of a novel cytokine, ML-1, and its expression in subjects with asthma.

    Mio Kawaguchi;Luiz F. Onuchic;Xiao-Dong Li;David M. Essayan

  • A genome-wide association study on African-ancestry populations for asthma.

    Rasika A. Mathias;Audrey V. Grant;Nicholas Rafaels;Tracey Hand

  • Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils

    Chao-Bo Guo;Mark C. Liu;Stephen J. Galli;Bruce S. Bochner

  • Asthma outcomes: pulmonary physiology.

    Robert S. Tepper;Robert S. Wise;Ronina Covar;Charles G. Irvin

  • Direct Assessment of Small Airways Reactivity in Human Subjects

    Elizabeth M. Wagner;Eugene R. Bleecker;Eugene R. Bleecker;Solbert Permutt;Mark C. Liu

  • Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions

    Bruce S. Bochner;Sherry A. Hudson;Hui Qing Xiao;Mark C. Liu

  • Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge.

    S. N. Georas;M. C. Liu;W. Newman;L. D. Beall

  • Allergen-induced sensory neuroplasticity in airways.

    Bradley J. Undem;Dawn D. Hunter;Mark Liu;Mary Haak-Frendscho

  • Cutting Edge: Expression of the C-C Chemokine Receptor CCR3 in Human Airway Epithelial Cells

    Cristiana Stellato;Mary E. Brummet;James R. Plitt;Syed Shahabuddin

  • The Effects of an Inhaled β2-Adrenergic Agonist on Lower Esophageal Function: A Dose-Response Study

    Michael D. Crowell;Estephan N. Zayat;Brian E. Lacy;Ann Schettler-Duncan

  • TLR9- and FcεRI-Mediated Responses Oppose One Another in Plasmacytoid Dendritic Cells by Down-Regulating Receptor Expression

    John T. Schroeder;Anja P. Bieneman;Hui Qing Xiao;Kristin L. Chichester

  • Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: Surface phenotype, density heterogeneity, and prostanoid production

    Claus Kroegel;Mark C. Liu;Walter C. Hubbard;Lawrence M. Lichtenstein

Frequent Co-Authors

Robert P. Schleimer
Robert P. Schleimer Northwestern University
Bruce S. Bochner
Bruce S. Bochner Northwestern University
Lawrence M. Lichtenstein
Lawrence M. Lichtenstein Johns Hopkins University
Dustin R. Rubenstein
Dustin R. Rubenstein Columbia University
Marc Humbert
Marc Humbert University of Paris-Saclay
Kenneth R. Chapman
Kenneth R. Chapman University of Toronto
Atsushi Kato
Atsushi Kato Northwestern University
John T. Schroeder
John T. Schroeder Johns Hopkins University
Ofer Levy
Ofer Levy Boston Children's Hospital
Robert C. Kern
Robert C. Kern Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Many students transition into clinical roles through programs like the nurse practitioner accelerated program, designed to fast-track licensed nurses into advanced practice roles.

Non-nurses aiming to enter the health sciences field might find online accelerated nursing programs for non nurses especially appealing. These programs offer streamlined paths to obtain nursing credentials without prior nurse training, complementing an Immunology background effectively.

For students seeking faster entry and less competitive admission, options such as the easiest accelerated nursing programs provide alternative routes with more flexible requirements.

Additionally, if you are exploring foundational nursing roles, lpn programs easy to get into offer accessible pathways to enter the healthcare workforce quickly, opening doors to clinical experience relevant to Immunology careers.

Best Scientists Citing Mark C. Liu

Trending Scientists

Recently Published Articles